MedTrace Logo

Impact of Blood Salvage Therapy on Outcomes After Oncologic Liver Surgery

NCT05164406 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2023-05-31

No results posted yet for this study

Summary

A before and after trial comparing the systematic use of blood salvage therapy with leucocyte filter during oncologic liver resections. Recurrence, survival, allogenic transfusion rates and surgical outcomes are compared with a representative historic cohort.

Conditions

  • Liver Neoplasms

Interventions

PROCEDURE

Blood salvage therapy

In the blood salvage group, blood is systematically given back when the minimal amount of blood loss required for reprocessing is met

Sponsors & Collaborators

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Yves Collin, MD · Université de Sherbrooke

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-08-01
Completion
2021-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05164406 on ClinicalTrials.gov